Similar articles

• [Multidrug resistance in lymphoproliferative syndromes].

  Damiani D, Michelutti A, Michieli M, Geromin A, Raspadori D, Giacca M, Mallardi F, Baccarani M. Damiani D, et al. Haematologica. 1991 Jun;76 Suppl 3:162-4. Haematologica. 1991. PMID: 1684341 Italian. No abstract available.
• Immunocytochemical detection of a resistance-associated glycoprotein in tissue culture cells, ascites tumors and human tumor xenografts by Mab 265/F4.

  Volm M, Bak M Jr, Efferth T, Lathan B, Mattern J. Volm M, et al. Anticancer Res. 1988 Jul-Aug;8(4):531-5. Anticancer Res. 1988. PMID: 2902821
• [Function of carbohydrate chains serving as tumor-markers and differentiation markers].

  Muramatsu T. Muramatsu T. Rinsho Byori. 1988 Nov;Spec No 79:27-36. Rinsho Byori. 1988. PMID: 3266884 Japanese. No abstract available.
• Altered glycoprotein sugar-chain structures as possible diagnostic and prognostic markers in malignant tumors.

  Yoshida K, Sumi S, Yano M, Suzuki T, Ueda Y. Yoshida K, et al. Int J Urol. 1995 Nov;2(5):281-7. Int J Urol. 1995. PMID: 8749945 Review. No abstract available.
• Multiple drug resistance.

  Leveille CR, Moore AS. Leveille CR, et al. Adv Vet Sci Comp Med. 1993;37:31-59. Adv Vet Sci Comp Med. 1993. PMID: 7903834 Review. No abstract available.